JP2019528793A5 - - Google Patents

Download PDF

Info

Publication number
JP2019528793A5
JP2019528793A5 JP2019538714A JP2019538714A JP2019528793A5 JP 2019528793 A5 JP2019528793 A5 JP 2019528793A5 JP 2019538714 A JP2019538714 A JP 2019538714A JP 2019538714 A JP2019538714 A JP 2019538714A JP 2019528793 A5 JP2019528793 A5 JP 2019528793A5
Authority
JP
Japan
Prior art keywords
vector
polynucleotide
adeno
promoter
associated virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019538714A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019528793A (ja
JP7059285B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/074081 external-priority patent/WO2018060097A1/en
Publication of JP2019528793A publication Critical patent/JP2019528793A/ja
Publication of JP2019528793A5 publication Critical patent/JP2019528793A5/ja
Application granted granted Critical
Publication of JP7059285B2 publication Critical patent/JP7059285B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019538714A 2016-09-30 2017-09-22 ムコ多糖症の治療のためのアデノ随伴ウイルスベクター Expired - Fee Related JP7059285B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16382450 2016-09-30
EP16382450.1 2016-09-30
PCT/EP2017/074081 WO2018060097A1 (en) 2016-09-30 2017-09-22 Adenoassociated virus vectors for the treatment of mucopolysaccharidoses

Publications (3)

Publication Number Publication Date
JP2019528793A JP2019528793A (ja) 2019-10-17
JP2019528793A5 true JP2019528793A5 (enExample) 2020-11-12
JP7059285B2 JP7059285B2 (ja) 2022-04-25

Family

ID=57123944

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019538714A Expired - Fee Related JP7059285B2 (ja) 2016-09-30 2017-09-22 ムコ多糖症の治療のためのアデノ随伴ウイルスベクター

Country Status (10)

Country Link
US (1) US11338046B2 (enExample)
EP (1) EP3519569B1 (enExample)
JP (1) JP7059285B2 (enExample)
CN (1) CN109863243B (enExample)
AR (1) AR109752A1 (enExample)
AU (1) AU2017333336B2 (enExample)
ES (1) ES2859661T3 (enExample)
PT (1) PT3519569T (enExample)
TW (1) TW201814044A (enExample)
WO (1) WO2018060097A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9309534B2 (en) 2010-07-12 2016-04-12 Universidad Autonoma De Barcelona Gene therapy composition for use in diabetes treatment
EP2692868A1 (en) 2012-08-02 2014-02-05 Universitat Autònoma De Barcelona Adeno-associated viral (AAV) vectors useful for transducing adipose tissue
KR20160010526A (ko) * 2013-05-15 2016-01-27 리젠츠 오브 더 유니버시티 오브 미네소타 중추 신경계로의 아데노-연관 바이러스 매개 유전자 전달
WO2016041588A1 (en) 2014-09-16 2016-03-24 Universitat Autònoma De Barcelona Adeno-associated viral vectors for the gene therapy of metabolic diseases
EP3227449B1 (en) 2014-12-05 2020-07-15 Universitat Autònoma de Barcelona Viral vectors for the treatment of diabetes
EP3242945B1 (en) 2015-01-07 2021-09-01 Universitat Autònoma de Barcelona Single-vector gene construct comprising insulin and glucokinase genes
KR102765034B1 (ko) 2017-05-24 2025-02-11 유니버시타트 아우토노마 데 바르셀로나 섬유아세포 성장 인자 21 (fgf21) 코딩 서열을 포함하는 바이러스 발현 컨스트럭트
AU2019261646A1 (en) 2018-04-27 2020-11-12 Spacecraft Seven, Llc Gene therapy for CNS degeneration
US12146169B2 (en) * 2018-05-30 2024-11-19 Esteve Pharmaceuticals, S.A. Adenoassociated virus vectors for the treatment of mucopolysaccharidoses type IV A
WO2020014523A1 (en) * 2018-07-12 2020-01-16 Rocket Pharmaceuticals, Ltd. Gene therapy vectors for treatment of danon disease
EP3914720B9 (en) 2019-07-10 2023-09-27 Masonic Medical Research Laboratory Vgll4 with ucp-1 cis-regulatory element and method of use thereof
CN111718947B (zh) * 2020-06-18 2022-08-23 舒泰神(北京)生物制药股份有限公司 用于治疗ⅲa或ⅲb型粘多糖贮积症的腺相关病毒载体及用途
IL300263A (en) 2020-08-07 2023-03-01 Spacecraft Seven Llc Plakophilin-2 (PKP2) gene therapy using an AAV vector
CN114480454B (zh) * 2020-10-27 2024-03-29 华东理工大学 用于治疗粘多糖贮积症ⅱ型的腺相关病毒载体、药物及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7232670B2 (en) * 2001-09-28 2007-06-19 St. Jude Children's Research Hospital Targeting proteins to cells expressing mannose receptors via expression in insect cells
CN101444621B (zh) * 2003-02-11 2013-11-20 夏尔人类遗传性治疗公司 使用甲酰-甘氨酸生成酶(fge)对多种硫酸酯酶缺乏症和其它病症进行诊断和治疗
EP2394667A1 (en) 2010-06-10 2011-12-14 Laboratorios Del Dr. Esteve, S.A. Vectors and sequences for the treatment of diseases
SG11201404741VA (en) 2012-02-07 2014-09-26 Global Bio Therapeutics Usa Inc Compartmentalized method of nucleic acid delivery and compositions and uses thereof
CN105916990B (zh) * 2013-08-02 2020-02-04 巴塞罗那自治大学 用于转导脂肪组织的腺相关病毒载体
WO2015060722A1 (en) * 2013-10-24 2015-04-30 Uniqure Ip B.V. Aav-5 pseudotyped vector for gene therapy for neurological diseases
GB201322798D0 (en) * 2013-12-20 2014-02-05 Oxford Biomedica Ltd Production system
US11149285B2 (en) * 2014-05-14 2021-10-19 Universitat Autónoma De Barcelona Adenoassociated virus vectors for the treatment of lysosomal storage disorders
CN116019934A (zh) * 2015-02-10 2023-04-28 建新公司 病毒颗粒至纹状体和皮质的增强递送
US9981021B1 (en) * 2015-04-09 2018-05-29 Kinetiq, Inc. Subcutaneous therapeutic enzyme formulations, uses, and methods for generating thereof

Similar Documents

Publication Publication Date Title
JP2018517414A5 (enExample)
RU2016149206A (ru) Аденоассоциированные вирусные векторы для лечения лизосомных болезней накопления
RU2017142006A (ru) Векторы на основе аденоассоциированных вирусов для лечения мукополисахаридозов
Komoto et al. Reverse genetics system demonstrates that rotavirus nonstructural protein NSP6 is not essential for viral replication in cell culture
JP2020022459A5 (enExample)
FI3313991T3 (fi) Muunnettu tekijä IX sekä koostumukset, menetelmät ja käytöt geeninsiirtoa varten soluihin, elimiin ja kudoksiin
JP2014239686A5 (enExample)
HRP20180146T1 (hr) Vektori i sljedovi namijenjeni liječenju bolesti
JP2018520997A5 (enExample)
BR112019016769A2 (pt) Métodos e composições para transferência genética através da vasculatura
JP2015523379A5 (enExample)
JP2019519219A5 (enExample)
JP2020522269A5 (enExample)
JP2020500541A5 (enExample)
JP2022514955A5 (enExample)
JP2016520290A5 (enExample)
JP2016538885A5 (enExample)
JP2013509168A5 (enExample)
JP2018534950A5 (enExample)
JP2016512683A5 (enExample)
JP2015521465A5 (enExample)
JP2014512171A5 (enExample)
JP2016028035A5 (enExample)
JP2014507145A (ja) 改変された形質導入プロファイルを有するウイルスベクターならびにその製造および使用の方法
JP2010516252A5 (enExample)